SANKYO C22
Generic Name: hydrochlorothiazide/olmesartan
Pill imprint SANKYO C22 has been identified as Benicar HCT 12.5 mg / 20 mg.
Benicar HCT is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy.
Benicar HCT 12.5 mg / 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Benicar HCT Images
- Generic Name:
- hydrochlorothiazide/olmesartan
- Imprint:
-
SANKYO
C22 - Strength:
- 12.5 mg / 20 mg
- Color:
- Yellow
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- hydroxypropyl cellulose
hypromellose
lactose
magnesium stearate
microcrystalline cellulose
ferric oxide red
magnesium silicate
titanium dioxide
ferric oxide yellow
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sankyo Pharma
- National Drug Code (NDC):
- 65597-0105
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5170 | Physicians Total Care Inc (repackager) |
| 35356-0256 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Benicar HCT resources
- Benicar HCT (Wolters Kluwer)
- Benicar HCT (Cerner Multum)
- Benicar HCT (Micromedex) - Includes Dosage Information
- Benicar HCT (FDA)
Search Again
